Paloma Partners’s Boston Scientific BSX Stock Holding History

Paloma Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,800	Closed	-$798K	–	798
2023 Q4	$798K	Buy	+13,800	New	+$737K	0.03%	458
2022 Q2	–	Sell	-72,200	Closed	-$3.2M	–	1166
2022 Q1	$3.2M	Buy	72,200 +21,500	+42%	+$932K	0.09%	137
2021 Q4	$2.15M	Buy	+50,700	New	+$2.13M	0.03%	439
2021 Q2	–	Sell	-18,500	Closed	-$715K	–	1809
2021 Q1	$715K	Sell	18,500 -443,300	-96%	-$16.8M	0.02%	874
2020 Q4	$16.6M	Buy	+461,800	New	+$16.6M	0.44%	32
2020 Q3	–	Sell	-42,900	Closed	-$1.51M	–	2106
2020 Q2	$1.51M	Buy	42,900 +21,400	+100%	+$771K	0.03%	741
2020 Q1	$701K	Buy	+21,500	New	+$840K	0.04%	390
2016 Q3	–	Sell	-40,000	Closed	-$935K	–	1846
2016 Q2	$935K	Hold	40,000	–	–	0.01%	1203
2016 Q1	$752K	Buy	+40,000	New	+$703K	0.01%	1066

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's BSX Position: Q4 2024 in Review

Paloma Partners sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 16,273 shares — an estimated $1.36M sold.

Paloma Partners first reported a position in BSX in Q2 2013 and held it in 29 quarters. The position peaked at $6.29M in Q4 2020. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

Paloma Partners reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
Paloma Partners sold 16,273 Boston Scientific shares in Q4 2024, an estimated $1.36M.
Paloma Partners first reported a position in Boston Scientific in Q2 2013 and held it in 29 quarters.
Paloma Partners's Boston Scientific position peaked at $6.29M in Q4 2020.
1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.